OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BMSR$326.0056

Bintang Mitra Semestaraya Tbk PT

Commodity ChemicalsVerified

The company maintains a liquidity position with a current ratio of 1.84, indicating a moderate ability to meet short-term obligations. However, its price-to-book ratio of 0.39 suggests that the market values the company's equity at a significant discount to its book value. The company's return on equity of 4.86% is below the typical benchmark for the industry, indicating suboptimal capital efficiency. Profitability metrics show a gross profit of 258.45 billion IDR and an operating income of 35.32 billion IDR, translating to a gross margin of 7.14% and an operating margin of 0.98%. These figures are below the median for the Commodity Chemicals industry, which typically sees higher margins due to the nature of chemical trading and distribution. The company's revenue is distributed across several segments, with the Chemical Goods & Rice segment being the primary contributor. Geographically, the company's sales are concentrated in Jabotabek, West Java, Central Java, East Java, and parts of Sumatra and Bontang. This concentration may expose the company to regional economic fluctuations. Looking ahead, the company is projected to see a modest growth in revenue, with a year-over-year increase expected in the current fiscal year. The outlook for the next fiscal year remains cautiously optimistic, with a projected growth rate that aligns with the broader industry trends. The company faces a medium liquidity risk, as indicated by the risk assessment, and a low dilution risk. The company's capital structure includes a long-term debt of 366.18 billion IDR, which is relatively low compared to its total equity of 959.40 billion IDR. The company's debt-to-equity ratio of 0.38 suggests a conservative approach to leverage. Recent events, including the company's financial filings and transcripts, indicate a focus on maintaining operational efficiency and managing debt levels. The company's recent capital expenditures have been minimal, with a negative value of -1.50 billion IDR, suggesting a focus on cost control and asset optimization.

30-day price · BMSR+6.00 (+2.0%)
Low$304.00High$380.00Close$312.00As of12 May, 00:00 UTC
Profile
CompanyBintang Mitra Semestaraya Tbk PT
TickerBMSR.JK
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. PT Bintang Mitra Semestaraya Tbk engages in the trading of chemical products for various industries, including caustic soda liquid, poly vinyl chloride, and sulfuric acid, and operates through segments such as Chemical Goods & Rice, share on Sale of Nickel, and Others.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.

The company maintains a liquidity position with a current ratio of 1.84, indicating a moderate ability to meet short-term obligations. However, its price-to-book ratio of 0.39 suggests that the market values the company's equity at a significant discount to its book value. The company's return on equity of 4.86% is below the typical benchmark for the industry, indicating suboptimal capital efficiency. Profitability metrics show a gross profit of 258.45 billion IDR and an operating income of 35.32 billion IDR, translating to a gross margin of 7.14% and an operating margin of 0.98%. These figures are below the median for the Commodity Chemicals industry, which typically sees higher margins due to the nature of chemical trading and distribution. The company's revenue is distributed across several segments, with the Chemical Goods & Rice segment being the primary contributor. Geographically, the company's sales are concentrated in Jabotabek, West Java, Central Java, East Java, and parts of Sumatra and Bontang. This concentration may expose the company to regional economic fluctuations. Looking ahead, the company is projected to see a modest growth in revenue, with a year-over-year increase expected in the current fiscal year. The outlook for the next fiscal year remains cautiously optimistic, with a projected growth rate that aligns with the broader industry trends. The company faces a medium liquidity risk, as indicated by the risk assessment, and a low dilution risk. The company's capital structure includes a long-term debt of 366.18 billion IDR, which is relatively low compared to its total equity of 959.40 billion IDR. The company's debt-to-equity ratio of 0.38 suggests a conservative approach to leverage. Recent events, including the company's financial filings and transcripts, indicate a focus on maintaining operational efficiency and managing debt levels. The company's recent capital expenditures have been minimal, with a negative value of -1.50 billion IDR, suggesting a focus on cost control and asset optimization.
Key takeaways
  • The company's liquidity position is moderate, with a current ratio of 1.84.
  • The company's return on equity of 4.86% is below the industry median, indicating suboptimal capital efficiency.
  • The company's revenue is concentrated in specific geographic regions, which may expose it to regional economic fluctuations.
  • The company's debt-to-equity ratio of 0.38 suggests a conservative approach to leverage.
  • The company's price-to-book ratio of 0.39 indicates that the market values the company's equity at a significant discount to its book value.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue$3.62T
Gross profit$258.45B
Operating income$35.32B
Net income$46.67B
R&D
SG&A
D&A
SBC
Operating cash flow$41.48B
CapEx-$1.50B
Free cash flow$51.99B
Total assets$1.81T
Total liabilities$854.87B
Total equity$959.40B
Cash & equivalents$3.02B
Long-term debt$366.18B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$326.00
Market cap$377.90B
Enterprise value$741.06B
P/E8.1
Reported non-GAAP P/E
EV/Revenue0.2
EV/Op income21.0
EV/OCF17.9
P/B0.4
P/Tangible book0.4
Tangible book$959.40B
Net cash-$363.16B
Current ratio1.8
Debt/Equity0.4
ROA2.6%
ROE4.9%
Cash conversion89.0%
CapEx/Revenue-0.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricBMSRActivity
Op margin1.0%0.4% medp25 -8.0% · p75 16.0%above median
Net margin1.3%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin7.1%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity38.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 12:52 UTC#b08615f5
Market quoteclose IDR 326.00 · shares 1.16B diluted
no public URL
2026-05-10 12:52 UTC#cefbaf21
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 12:55 UTCJob: 362b999f